Cargando…
Relationship between plasma high mobility group box-1 protein levels and clinical outcomes of aneurysmal subarachnoid hemorrhage
BACKGROUND: High-mobility group box 1 (HMGB1), originally described as a nuclear protein that binds to and modifies DNA, is now regarded as a central mediator of inflammation by acting as a cytokine. However, the association of HMGB1 in the peripheral blood with disease outcome and cerebrovasospasm...
Autores principales: | Zhu, Xiang-Dong, Chen, Jing-Sen, Zhou, Feng, Liu, Qi-Chang, Chen, Gao, Zhang, Jian-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424135/ https://www.ncbi.nlm.nih.gov/pubmed/22883976 http://dx.doi.org/10.1186/1742-2094-9-194 |
Ejemplares similares
-
Detection of copeptin in peripheral blood of patients with aneurysmal subarachnoid hemorrhage
por: Zhu, Xiang-Dong, et al.
Publicado: (2011) -
Plasma gelsolin levels and outcomes after aneurysmal subarachnoid hemorrhage
por: Pan, Jian-Wei, et al.
Publicado: (2013) -
Targeting High Mobility Group Box 1 in Subarachnoid Hemorrhage: A Systematic Review
por: Muhammad, Sajjad, et al.
Publicado: (2020) -
Aneurysmal Subarachnoid Hemorrhage
por: D’Souza, Stanlies
Publicado: (2015) -
Prognostic value of plasma galectin‐3 levels after aneurysmal subarachnoid hemorrhage
por: Liu, Hua, et al.
Publicado: (2016)